pancreatic

  1. T

    Pancreatic Ductal Adenocarcinoma: A New Therapeutic Intervention

    Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant digestive tumor with a very poor prognosis. Hypoxia-inducible transcription factor-1α (HIF-1α) is involved in malignant progression in many solid tumors, including PDAC, upregulation of HIF-1α accelerates PDAC progression, but the...
  2. T

    Detection And Removal Of Pancreatic Cysts May Lower Cancer Risk

    Working with researchers from the University of Michigan and Indiana University, Van Andel Research Institute (VARI) investigators have developed a method that could be used to predict whether pancreatic cysts are benign or are precursors to invasive cancer. More pancreatic cysts are being...
  3. T

    In Patients With Pancreatic Disease, Quality-Of-Life Testing May Predict Malignancy A

    Quality-of-life measures used routinely to assess treatment outcomes for patients with pancreatic disease may be used to predict both malignancy and survival for those patients, according to a study by Henry Ford Hospital. Researchers found that pre-treatment quality-of-life scores could predict...
  4. T

    The Lustgarten Foundation Forms National Pancreatic Cancer Research Consortium Led By

    The Lustgarten Foundation announced that it has formed a national pancreatic cancer research consortium, a collaborative effort involving six world-renowned medical institutions to advance the most promising research initiatives aimed at finding a cure for pancreatic cancer. Named the Pancreatic...
  5. T

    Having A Family Member Under 50 Diagnosed With Pancreatic Cancer Increases Risk

    A person who has multiple family members with pancreatic cancer ("familial pancreatic cancer") is six times as likely to develop that cancer. This risk is even higher, nine times that of the general population, if one of their relatives developed their cancer under the age of 50, according to a...
  6. T

    Having A Family Member Under 50 Diagnosed With Pancreatic Cancer Increases Risk

    A person who has multiple family members with pancreatic cancer ("familial pancreatic cancer") is six times as likely to develop that cancer. This risk is even higher, nine times that of the general population, if one of their relatives developed their cancer under the age of 50, according to a...
  7. T

    Clavis Pharma Receives US Orphan Drug Designation For CP-4126 To Treat Pancreatic Can

    Clavis Pharma (OSE: CLAVIS); the Norwegian cancer drug development company, announced today that the US Food & Drug Administration (FDA) has granted orphan drug designation to CP-4126 for the treatment of pancreatic cancer. The designation follows the equivalent designation given by the European...
  8. T

    Use Of 3-D Imaging On Patients With Pancreatic Carcinoma

    In the field of hepatic imaging in the context of living liver donors and before complex partial liver resections, three-dimensional imaging of the liver, hepatic vessels and bile ducts has managed to become established in some centers. In this case, in addition to visualization, the volumetry...
  9. T

    Use Of 3-D Imaging On Patients With Pancreatic Carcinoma

    In the field of hepatic imaging in the context of living liver donors and before complex partial liver resections, three-dimensional imaging of the liver, hepatic vessels and bile ducts has managed to become established in some centers. In this case, in addition to visualization, the volumetry...
  10. T

    The Utility Of EUS And CEH-EUS In The Diagnosis Of Small Pancreatic Tumors

    Endoscopic ultrasonography (EUS) is a highly sensitive diagnostic method for the detection of small pancreatic carcinomas. Recently, there have been some reports describing the utility of contrast-enhanced harmonic EUS (CEH-EUS) which uses sonographic contrast agent for differentiation of a...
Back
Top